Back to Search

A Phase 1, First in Human, Dose-Escalation Study of TORL-3-600 in Participants With Advanced Cancer


  • Protocol Number: 202310135
  • Principal Investigator: Khushman, Moh'd
  • Cancer Types: Gastrointestinal

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions